We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Luminescent Magnetic Nanoparticles Used for Diagnostic Tests

By Biotechdaily staff writers
Posted on 12 Feb 2007
A new type of nanoparticle has been created that could be used in tests for medical diagnostics, environmental pollution, or contamination of food products.

The particles, about 100 to 200 nm in size, are luminescent, magnetic, and inexpensive to make, and can be tagged with antibodies. More...
They are made up of a magnetic core of iron oxide or iron/neodymium/cobalt oxide coated in a shell of europium and gadolinium oxide. When stimulated with a laser, europium emits red light at a very specific wavelength.

The nanoparticles can be manipulated with magnets and detected by fluorescence. They could also be labeled with other fluorescent labels in different colors, or used as part of an assay with other fluorescent labels. The built-in europium luminescence acts as an internal standard, making it easier to carry out accurate quantitative assays, said Ian Kennedy, professor of mechanical and aeronautical engineering at the University of California Davis (Davis, CA, USA), and senior author of a paper describing the work. The paper is published in the online journal Nanotechnology and will appear in the February 7, 2007, print issue of the journal.

The particles can also be coated with short pieces of DNA and used for genetic analysis. The team is exploring uses including testing for bioterrorism agents such as ricin or botulinum toxin in food and for genetic tests in cancer medicine.

The nanoparticles were made by spray pyrolysis, which involves mixing the raw material in a solvent and spraying it through a flame. The method is much cheaper than the techniques previously used for making similar particles, and can readily be scaled up to industrial production. It is already used in the chemical industry to make products such as fumed silica and carbon black.

The researchers are establishing a company, Synthia LLC, to develop the technology further.



Related Links:
University of California Davis

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.